The proposal targets Budenheim’s and Prayon’s stakes, each representing one third of the capital. The purchases would follow separate schedules: the first would give OCP exclusive control, the second full ownership.
EMAPHOS produces purified phosphoric acid at Jorf Lasfar. Notification does not establish merger clearance or completion of the acquisition.